ProPhase Labs, Inc. Increase (Decrease) in Prepaid Expenses, Other
ProPhase Labs, Inc. (PRPH) reported Increase (Decrease) in Prepaid Expenses, Other of -$185.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2019-03-26
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2018-12-31 was -$57.00K.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2018-09-30 was $4.00K.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2018-06-30 was -$212.00K, a 184.46% decline year-over-year.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2018-03-31 was $80.00K.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for fiscal 2018 was -$185.00K.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for fiscal 2017 was -$199.00K.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for fiscal 2016 was -$1.20M, a 350.83% decline from fiscal 2015.
- ProPhase Labs, Inc. increase (decrease) in prepaid expenses, other for fiscal 2015 was $480.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$53.00K derived: sum of 2 quarters · filed 2019-03-26 | -$265.00K derived: sum of 3 quarters · filed 2019-03-26 | -$185.00K 10-K · filed 2019-03-26 |
| 2018-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$208.00K derived: sum of 2 quarters · filed 2018-11-14 | -$128.00K 10-Q · filed 2018-11-14 | -$215.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2018-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$132.00K 10-Q · filed 2018-08-20 | -$219.00K derived: sum of 3 quarters · filed 2019-03-26 | -$500.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2018-03-31 | $80.00K 10-Q/A · filed 2018-08-20 | -$7.00K derived: sum of 2 quarters · filed 2019-03-26 | -$288.00K derived: sum of 3 quarters · filed 2019-03-26 | -$37.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$368.00K derived: sum of 2 quarters · filed 2019-03-26 | -$117.00K derived: sum of 3 quarters · filed 2019-03-26 | -$199.00K 10-K · filed 2019-03-26 |
| 2017-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$30.00K derived: sum of 2 quarters · filed 2018-11-14 | -$112.00K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $251.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $169.00K 10-Q/A · filed 2018-08-20 | ||
| 2017-03-31 | -$82.00K 10-Q/A · filed 2018-08-20 | |||
| 2016-12-31 | -$1.20M 10-K/A · filed 2018-08-20 | |||
| 2016-06-30 | -$703.00K 10-Q/A · filed 2018-08-20 | |||
| 2015-12-31 | $480.00K 10-K/A · filed 2018-08-20 | |||
| 2014-12-31 | -$397.00K 10-K · filed 2017-02-24 | |||
| 2013-12-31 | -$886.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |